Randomized double blind placebo controlled trial of vitamin D supplements, with or without calcium supplementation, versus placebo in reduction of recurrences in BPPV.
Age 18 years or older
2 or more distinct episodes of benign paroxysmal positional vertigo within a 12-month period on history
At least 1 episode diagnosed based on physical examination by trained study personnel, meeting the diagnostic criteria of the Bárány Society
Episodes separated in time, with a minimum of 1 week symptom-free between episodes
have another identifiable cause of vertigo identified on history or physical examination
have a history of allergy or medically significant adverse reaction to vitamin D or calcium carbonate
have a chronic medical disorder which is a contraindication to vitamin D or calcium carbonate supplementation, including uncontrolled hyperparathyroidism, nephrolithiasis, or GI malabsorption disorders
are on loop diuretic agents or thiazides
Parallel
vitamin D +/- calcium
Dietary supplementvitamin D 1000iU daily +/- calcium 500mg BID daily
Placebo
Other interventionplacebo pill x3 daily
Recurrence rate of BPPV
how many recurrences of BPPV
serum vitamin D levels (25(OH)D3)
serum vitamin D levels
proportion of serum vitamin D normalization
do patients normalize
time to serum vitamin D normalization
how long does it take patients to normalize
proportion of recurrences
what proportion of total patients have recurrences
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
